| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL1900041 | 重组人源化抗HER2单抗-MMAE偶联药物注射液 | Recombinant Humanized Anti-HER2-MMAE | Injection | Biological Products(1) | New Drug Application | 2019-05-09 | 石药集团中奇制药技术（石家庄）有限公司 | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd | In Review | 2019-05-07 | view |